{18 (oteseconazole 150 MG Oral Capsule) } Pack
- RxCUI
- 2605802
- RxNorm name
- {18 (oteseconazole 150 MG Oral Capsule) } Pack
- Display name
- {18 (oteseconazole 150 MG Oral Capsule) } Pack
- Full name
- {18 (oteseconazole 150 MG Oral Capsule) } Pack
- Term type
- GPCK
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:25
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VIVJOA | OTESECONAZOLE | Mycovia Pharmaceuticals, Inc. | e21d5008-800e-4417-927f-14340341865f | 2026-01-08 | Warnings, Adverse reactions | 2605802 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| e21d5008-800e-4417-927f-14340341865f | {18 (oteseconazole 150 MG Oral Capsule) } Pack | GPCK | 5 | These highlights do not include all the information needed to use VIVJOA™ safely and effectively. See full prescribing information for VIVJOA™. VIVJOA™ (oteseconazole) capsules, for oral use Initial U.S. Approval: 2022 | 20260108 |
| e21d5008-800e-4417-927f-14340341865f | oteseconazole 150 MG 18-Count Pack | PSN | 5 | These highlights do not include all the information needed to use VIVJOA™ safely and effectively. See full prescribing information for VIVJOA™. VIVJOA™ (oteseconazole) capsules, for oral use Initial U.S. Approval: 2022 | 20260108 |
| e21d5008-800e-4417-927f-14340341865f | oteseconazole 150 MG 18-Count Pack | SY | 5 | These highlights do not include all the information needed to use VIVJOA™ safely and effectively. See full prescribing information for VIVJOA™. VIVJOA™ (oteseconazole) capsules, for oral use Initial U.S. Approval: 2022 | 20260108 |